A federal judge didn’t wait for an English court to decide on the arbitrability of a case between Teva Pharmaceuticals and an excess patent insurer before sending the case there for arbitration.
U.S. District Judge Gene E.K. Pratter of the Eastern District of Pennsylvania decided that the arbitration clause in Teva’s contract for its primary patent insurance had been extended to its excess patent insurance coverage and, under the terms of the primary agreement, arbitration is to happen in London.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
